This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CME Group Inc (CME)

NASDAQ: Financial

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 1.13B 978.10M 906.70M 1.81B
Operating Gains/Losses -8.60M 25.10M -89.50M -5.50M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -38.50M -35.50M -300.00K -13.20M
(Increase) Decrease in Inventories 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 3.70M -2.60M -68.90M -96.50M
(Decrease) Increase In Payables 700.00K -5.50M 11.20M -21.00M
(Decrease) Increase In Other Current Liabilities -151.70M -9.30M 61.60M -4.80M
(Increase) Decrease In Other Working Capital -14.30M 37.60M -5.60M -6.50M
Other Non-Cash Items 61.10M 60.50M 61.00M 77.60M
Net Cash From Continuing Operations 1.29B 1.28B 1.22B 1.35B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 1.29B 1.28B 1.22B 1.35B
Sale of Property, Plant & Equipment 0.00 192.40M 151.50M 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment 0.00 -125.60M -141.80M -172.20M
Acquisitions 0.00 0.00 -120.50M 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -177.30M 127.80M 5.10M 17.50M
Cash Provided by Financing Activities
Net Cash From Investing Activities -199.10M 190.50M -206.00M -153.60M
Issuance of Debt 0.00 748.70M 747.70M 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 53.30M 73.70M 26.70M 6.40M
Repayment of Long-Term Debt -750.00M -750.00M 0.00 -420.50M
Repurchase of Capital Stock 0.00 0.00 0.00 -220.40M
Payment of Cash Dividends -1.50B -599.10M -1.22B -372.80M
Other Financing Charges, Net -2.40M -79.30M 1.50M 1.70M
Net Cash From Financing Activities -2.20B -606.00M -448.40M -1.01B
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents -1.10B 865.00M 562.40M 187.10M
CME News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for CME

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 4 4
Moderate Buy 0 0 0 0
Hold 5 4 5 5
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0

CME Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs